Intrathecal MTX for DLBCL: from an inappropriate prophylactic tradition to a medical error?
ContributorsDietrich, Pierre-Yves
Published inBlood, vol. 114, no. 9, 1999; author reply 1999
Publication date2009
Keywords
- Antibodies, Monoclonal/*adverse effects/immunology/*therapeutic use
- Antineoplastic Combined Chemotherapy Protocols/*adverse effects/*therapeutic use
- Central Nervous System Diseases/*chemically induced/prevention & control
- Combined Modality Therapy
- Cyclophosphamide/therapeutic use
- Doxorubicin/therapeutic use
- Humans
- Immunotherapy
- Injections, Spinal/*methods
- Lymphoma, Large B-Cell, Diffuse/*drug therapy/*immunology/pathology/radiotherapy
- Medical Errors
- Methotrexate/*adverse effects/*therapeutic use
- Prednisone/therapeutic use
- Research Design
- Risk
- Treatment Outcome
- Vincristine/therapeutic use
Affiliation entities
Research groups
Citation (ISO format)
DIETRICH, Pierre-Yves. Intrathecal MTX for DLBCL: from an inappropriate prophylactic tradition to a medical error? In: Blood, 2009, vol. 114, n° 9, p. 1999; author reply 1999. doi: 10.1182/blood-2009-05-222570
Main files (1)
Article
Identifiers
- PID : unige:19776
- DOI : 10.1182/blood-2009-05-222570
- PMID : 19713482
Journal ISSN0006-4971
